LUNG MALIGNANCIES AFTER BREAST CANCER/HODGKINS DISEASE

这项研究的目的是提供关于风险的新知识 乳腺癌放疗和化疗所致的第二原发癌 癌症和霍奇金氏病，并量化风险在长期 幸存者。用于分子分析和诊断的组织病理学材料 还将收集确认信息。总体而言，预计花名册 的乳腺癌或霍奇金氏病患者将接受计算机治疗 与第二原发癌登记报告的联系。详细 关于最初和随后的疗程的信息将是 为后续肺癌和匹配的肺癌患者提取的 无第二原发癌的对照组。

The objectives of this study are to provide new knowledge about the risk of second primary lung cancer due to radiation and chemotherapy for breast cancer and Hodgkin's disease, and to quantify risk among longterm survivors. Histopathologic material for molecular analyses and diagnostic confirmation will also be collected. Overall it is envisioned that rosters of patients with breast cancer or Hodgkin's disease will undergo computer linkage with registry reports of second primary lung cancers. Detailed information on initial and subsequent courses of therapy will be abstracted for patients who developed subsequent lung cancer and a matched control group without second primary cancers.